<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03078140</url>
  </required_header>
  <id_info>
    <org_study_id>4298</org_study_id>
    <nct_id>NCT03078140</nct_id>
  </id_info>
  <brief_title>Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation</brief_title>
  <official_title>The Study to Compare Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ChaingMai University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ChaingMai University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregnant women who attend at our antenatal clinic will random to 2 groups. First will receive
      routine iodine supplementation. The other will receive iodinated pill or only iron
      supplementation base on their urine iodine status.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>iodine status</measure>
    <time_frame>at delivery</time_frame>
    <description>mean urine iodine</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Iodine Deficiency</condition>
  <arm_group>
    <arm_group_label>Triferdine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Triferdine 1 tablet by mouth daily. Start after 1st trimester until delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Triferdine/Ferli-6</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Triferdine or ferli-6 1 tablet by mouth daily base on iodine status. The supplement will give after 1st trimester until delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Triferdine</intervention_name>
    <description>Triferdine 1 tablet daily Start from 14 weeks of gestation until delivery</description>
    <arm_group_label>Triferdine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Triferdine/Ferli-6</intervention_name>
    <description>For the participants assigned to this group, urine iodine level will be checked first.
For participants with normal urine iodine level, Ferli-6 1 tab daily will be given.
For those with low urine iodine level, Triferdine 1 tab daily will be given. Medication will be started from 14 weeks of gestation until delivery.</description>
    <arm_group_label>Triferdine/Ferli-6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  first visit for antenatal care in the first trimester

          -  singleton pregnancy

          -  delivered at Maharaj Nakorn Chiangmai Hospital

        Exclusion Criteria:

          -  thyroid disease which diagnosed before pregnancy or currently

          -  history of thyroid gland surgery or iodine ablation therapy

          -  received iodine supplement before pregnancy

          -  received any medication for thyroid disease treatment, within 6 weeks postpartum women
             or breast feeding period

          -  family history of thyroid disease

          -  having underlying disease or contraindication which cannot received iodine supplement

          -  loss follow-up or incomplete data.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Panja Kulapongs</last_name>
    <phone>6653936643</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Kuntharee Traisrisilp</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kuntharee Traisrisilp, M.D.</last_name>
      <phone>6653936429</phone>
      <email>kuntharee.t@cmu.ac.th</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2017</study_first_posted>
  <last_update_submitted>March 13, 2017</last_update_submitted>
  <last_update_submitted_qc>March 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ChaingMai University</investigator_affiliation>
    <investigator_full_name>Kuntharee Traisrisilp</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Cadexomer iodine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

